Contact this trialFirst, we need to learn more about you.
Remimazolam vs Midazolam for Cataract
Recruiting3 awardsPhase 4
Los Angeles, California
This trial is testing two anxiety-reducing medications, Midazolam and Remimazolam, in elderly patients having cataract surgery. The goal is to see if Remimazolam causes fewer cognitive side effects compared to Midazolam. Patients will take a cognitive test to measure any changes. Remimazolam is a newly developed medication with quicker effects than Midazolam.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service